Interview: Aaron Motsoaledi – Minister of Health, South Africa
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
Address: 378 Roan Crescent, Corporate Part North, Randjespark,South Africa
Tel: +27115429500
Web: http://www.lithahealthcare.co.za/company-structure/pharmaceuticals/litha-pharma/pharmafrica.html
Pharmafrica (Pty) Ltd has been in business since 1995. It became a full member of the Litha Group in 2010 but has been in a partnership with Litha since 2006.
The company markets ethical and complimentary healthcare products to niche markets through a wholesaler and direct distribution network. Pharmafrica has a solid reputation and strong relationships within the hospital and specialist environment and are an approved GMP manufacturer.
Pharmafrica is also a member of SMASA (Self Medication Manufacturers Association of South Africa)
Key markets:
Hospitals – Private and Public
Selected Medical Specialists and GP’s
Clinics – Private and Public
Academic Institutions
Retail Pharmacy
Pharmafrica has representatives in all the major areas of South Africa and primarily target the following specialities:
Cardiology
Dermatology
Plastic Surgery
Ophthalmology
Urology
General Medical Practice
Ethical medicines:
Analgesics
Anti-psychotics
Anti-depressants
Viscoelastic in eye surgery
Ophthalmic products
Anti-glaucoma therapy
Urinary incontinence
Topical anti-inflammatories
Complementary medicines:
Nutritive supplements
Vitamin supplements
Scar Management and stretch marks
Ageing and sun damaged skin preparations
Pharmafrica head office is located in Johannesburg and distributes from their warehouse nationally. They have a regional office in Cape Town and a total of 14 sales representatives. The company has regulatory, financial,/admin, marketing, distribution and sales resources and a total of 32 employees.
Pharmafrica represents the following companies:
Goldshield Pharmaceuticals – United Kingdom
Thornton & Ross LTD. – United Kingdom
Bio-technology General (B.T.G) – Israel
Apogepha Arzneimittel GMBH – Germany
Sankyo Pharma – Germany
Ursapharm – Germany
Products:
Cerumol – Ear Drops for ear care
Biolon Prime – Eye care
Biolone – Eye care
Ecotrin – Therapy for Cardiovascular Disease
Stelazine – Treatment of acute and chronic psychoses
Detrunorm – Therapy for an overactive bladder
Elmetacin – Topical NSAIDS
Dyazide – Treatment of fluid retention (edema) and high blood pressure (hypertension).
Diamox- Treatment for Glaucoma
Parnate – Antidepressant
Kamillosan – Baby care ointment
Oculet – Eye care
DS-24 – Nutritional supplement
Trimega – Omega Nutritional supplement
Dermastine Range – Skin and Scar Care
Flexeze Capsules and Gel – Therapy for Arthritis
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
The managing director of Southern Medical, Malan de Villiers illustrates the sheer diversity of the company’s current activities and portfolio within South Africa as a leading implant devices company, while…
Charl Louw, Vice President Africa and Middle East at Acelity discusses the challenges of a two-tiered health system for Acelity, the significance of South Africa for the company’s global portfolio…
The managing director of MC Pharma Group, Henk Krebs illustrates how MC Pharma’s new operating structure enables the group to better service its clients, and also highlights the role of…
Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory…
The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare…
The founder and managing director of LT Clinical Research, one of the first wholly black-owned South African CRO, reveals how South Africa is a very conducive environment for CROs, with…
The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why…
CEO of the Clicks Group, David Kneale highlights the motivations behind groups involvement in the Public Health Enhancement Fund (PHEF), and also describe the key strategies that have allowed Clicks…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
See our Cookie Privacy Policy Here
